Vorinostat Completed Phase 1 / 2 Trials for Graft Versus Host Disease (GVHD) / Malignancies, Hematologic Treatment

IndicationsStatusPurposePhase
CompletedTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs